Latest Simsen Diagnostics News & Updates

See the latest news and media coverage for Simsen Diagnostics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Simsen Diagnostics

Ultra-sensitive ctDNA analysis provider

simsendiagnostics.com
Headquarters
Mölndal, Sweden
Founded year
2020
Company type
Private company
Number of employees
5–10

Latest news about Simsen Diagnostics

Company announcements

  • Simsen Diagnostics

    Simsen Diagnostics highlights ctDNA studies detecting relapses early

    Studies using SiMSen-Seq detected ctDNA rises months before scans in rhabdomyosarcoma and neuroblastoma patients. They offer full-service monitoring and Personal LabSuite, seeking European partners.

  • Simsen Diagnostics

    Simsen Diagnostics partners with One-carbon Therapeutics for ODIN cancer trial

    Simsen deploys Simsen® Personal to monitor ctDNA in the Phase 1/2 trial evaluating TH9619 for solid cancers. The collaboration aims to detect minimal residual disease and guide dosing.

  • Simsen Diagnostics

    Simsen Diagnostics announces hospital laboratory solution

    Partners with Swedish hospital for tumour-informed ctDNA analysis. Provides panels, reagents, and support for seamless integration, efficiency, and precision oncology.

  • Simsen Diagnostics

    Simsen Diagnostics announces collaboration with Buzzard Pharmaceuticals

    Simsen partners for ultrasensitive ctDNA analysis in Buzzard's Phase IIa colorectal cancer trial using SiMSen-Seq platform. CEOs express enthusiasm.

Unlock all announcements with a

Media coverage

Be the first to know. to get notified the second Simsen Diagnostics hits the news.

Never miss news about Simsen Diagnostics

Track Simsen Diagnostics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.